Research & publications
Original research is at the heart of what we do. For more than 60 years, our experts have published across a wide range of topics from the fundamentals of health economics itself to the challenges facing health care in the UK and internationally.
The latest research and publications
The value of cell and gene therapies to the UK economy
Cell and gene therapies (CGTs) are moving rapidly from specialist trials to routine care: more than thirty products are already licensed worldwide and over two thousand are in clinical development. Their promise—a single intervention that can arrest or even cure previously intractable diseases—creates both opportunity and pressure for health systems.
The broader economic benefits of COVID-19 vaccination
Why investigating the economic case for ongoing COVID-19 vaccination matters While public health strategies around COVID-19 have transitioned from a pandemic to an endemic setting, the…
Understanding the preferences of people with acute leukemia for different health outcomes
When we want to understand or measure someone’s “health-related quality-of-life”, we typically ask them to describe the problems they have with different aspects of their health. In this study, we wanted to understand which aspects, or “dimensions”, of health-related quality-of-life are most important to the general public and to persons with acute leukemia.
Understanding the preferences of people with acute leukemia for different health outcomes
When we want to understand or measure someone’s “health-related…
Taking STRIDES: The value of diagnostics against AMR
Addressing a critical gap in AMR policy and evaluation Antimicrobial resistance…
Altering the trajectory of HIV in Europe
Despite substantial medical advancements that have transformed HIV into a…
Understanding the Full Value of Long-Acting Therapies: less is more?
Long-acting (LA) therapies represent a significant innovation in pharmaceutical…
An Analysis of NICE’s Optimised Decisions from 2015 to 2024
The National Institute for Health and Care Excellence (NICE) is the body…
Analysing Global Immunisation Expenditure
Immunisation programmes are foundational to public health. Organised by health…
The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region
Health Technology Assessment (HTA) agencies evaluate and make decisions on the…
Challenges and Solutions for Budget Impact Analysis of Gene Therapies
Gene therapies represent a paradigm shift in medicine, offering the potential…
The Importance of Diversity of Supply in Rare Diseases Markets
Rare disease medicine markets often rely on single suppliers, increasing the…
2023 OHE Annual Report to the Charity Commission
We are pleased to submit our seventh submission to the Charity Commission for…